{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:54:32Z","timestamp":1792616072893,"version":"4.5.0"},"reference-count":191,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T00:00:00Z","timestamp":1496102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T00:00:00Z","timestamp":1496102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Cell. Biochem."],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1002\/jcb.25895","type":"journal-article","created":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T17:26:35Z","timestamp":1484933195000},"page":"2484-2501","source":"Crossref","is-referenced-by-count":165,"title":["Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer"],"prefix":"10.1002","volume":"118","author":[{"given":"Muhammad","family":"Tariq","sequence":"first","affiliation":[{"name":"Zhejiang Province Key Laboratory of Anti-Cancer Drug Research; Institute of Pharmacology and Toxicology; College of Pharmaceutical Sciences; Zhejiang University; Hangzhou 310058 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqiong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zhejiang Province Key Laboratory of Anti-Cancer Drug Research; Institute of Pharmacology and Toxicology; College of Pharmaceutical Sciences; Zhejiang University; Hangzhou 310058 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guikai","family":"Liang","sequence":"additional","affiliation":[{"name":"Zhejiang Province Key Laboratory of Anti-Cancer Drug Research; Institute of Pharmacology and Toxicology; College of Pharmaceutical Sciences; Zhejiang University; Hangzhou 310058 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Ding","sequence":"additional","affiliation":[{"name":"Zhejiang Province Key Laboratory of Anti-Cancer Drug Research; Institute of Pharmacology and Toxicology; College of Pharmaceutical Sciences; Zhejiang University; Hangzhou 310058 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaojun","family":"He","sequence":"additional","affiliation":[{"name":"Zhejiang Province Key Laboratory of Anti-Cancer Drug Research; Institute of Pharmacology and Toxicology; College of Pharmaceutical Sciences; Zhejiang University; Hangzhou 310058 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[{"name":"Zhejiang Province Key Laboratory of Anti-Cancer Drug Research; Institute of Pharmacology and Toxicology; College of Pharmaceutical Sciences; Zhejiang University; Hangzhou 310058 China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,5,30]]},"reference":[{"key":"10.1002\/jcb.25895-BIB0001|jcb25895-cit-0001","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.imlet.2003.09.013","article-title":"A dual role for tumor-derived chemokine RANTES (CCL5)","volume":"90","author":"Adler","year":"2003","journal-title":"Immunol Lett"},{"key":"10.1002\/jcb.25895-BIB0002|jcb25895-cit-0002","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ccr.2014.04.026","article-title":"B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas","volume":"25","author":"Affara","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1002\/jcb.25895-BIB0003|jcb25895-cit-0003","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1158\/0008-5472.CAN-04-0961","article-title":"Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice","volume":"64","author":"Aharinejad","year":"2004","journal-title":"Cancer Res"},{"key":"10.1002\/jcb.25895-BIB0004|jcb25895-cit-0004","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO;2-4","article-title":"IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages","volume":"28","author":"Allavena","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1002\/jcb.25895-BIB0005|jcb25895-cit-0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2007.07.004","article-title":"The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages","volume":"66","author":"Allavena","year":"2008","journal-title":"Criti Rev Oncol Hematol"},{"key":"10.1002\/jcb.25895-BIB0006|jcb25895-cit-0006","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4048\/jbc.2015.18.4.329","article-title":"Synergistic effect of trabectedin and olaparib combination regimen in Breast cancer cell lines","volume":"18","author":"\u00c1vila-Arroyo","year":"2015","journal-title":"J Breast Cancer"},{"key":"10.1002\/jcb.25895-BIB0007|jcb25895-cit-0007","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood.V87.8.3336.bloodjournal8783336","article-title":"Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1","volume":"87","author":"Barleon","year":"1996","journal-title":"Blood"},{"key":"10.1002\/jcb.25895-BIB0008|jcb25895-cit-0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-016-2166-5","article-title":"Tumor-associated macrophages and anti-tumor therapies: Complex links","volume":"73","author":"Belgiovine","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"10.1002\/jcb.25895-BIB0009|jcb25895-cit-0009","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1084\/jem.190.10.1417","article-title":"In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas","volume":"190","author":"Bell","year":"1999","journal-title":"J Exp Med"},{"key":"10.1002\/jcb.25895-BIB0010|jcb25895-cit-0010","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.4049\/jimmunol.1103378","article-title":"Wnt5a induces a tolerogenic phenotype of macrophages in sepsis and breast cancer patients","volume":"188","author":"Bergenfelz","year":"2012","journal-title":"J Immunol"},{"key":"10.1002\/jcb.25895-BIB0011|jcb25895-cit-0011","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.4049\/jimmunol.168.12.6404","article-title":"Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation","volume":"168","author":"Berlato","year":"2002","journal-title":"J Immunol"},{"key":"10.1002\/jcb.25895-BIB0012|jcb25895-cit-0012","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1189\/jlb.0310153","article-title":"NF-\u03baB as a central regulator of macrophage function in tumors","volume":"88","author":"Biswas","year":"2010","journal-title":"J Leukoc Biol"},{"key":"10.1002\/jcb.25895-BIB0013|jcb25895-cit-0013","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1002\/jcb.25895-BIB0014|jcb25895-cit-0014","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1016\/j.biomaterials.2012.02.034","article-title":"Macrophage polarization: An opportunity for improved outcomes in biomaterials and regenerative medicine","volume":"33","author":"Brown","year":"2012","journal-title":"Biomaterials"},{"key":"10.1002\/jcb.25895-BIB0015|jcb25895-cit-0015","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/leu.2008.237","article-title":"Dasatinib is a potent inhibitor of tumour-associated macrophages, osteoclasts and the FMS receptor","volume":"23","author":"Brownlow","year":"2009","journal-title":"Leukemia"},{"key":"10.1002\/jcb.25895-BIB0016|jcb25895-cit-0016","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.4049\/jimmunol.174.10.6013","article-title":"CD40 ligation activates murine macrophages via an IFN-\u03b3-dependent mechanism resulting in tumor cell destruction in vitro","volume":"174","author":"Buhtoiarov","year":"2005","journal-title":"J Immunol"},{"key":"10.1002\/jcb.25895-BIB0017|jcb25895-cit-0017","first-page":"21454","article-title":"Does estrogen receptor determination affect prognosis in early stage breast cancers","volume":"8","author":"Bulut","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1002\/jcb.25895-BIB0018|jcb25895-cit-0018","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/path.1029","article-title":"Expression of HIF-1\u03b1 by human macrophages: Implications for the use of macrophages in hypoxia-regulated cancer gene therapy","volume":"196","author":"Burke","year":"2002","journal-title":"J Pathol"},{"key":"10.1002\/jcb.25895-BIB0019|jcb25895-cit-0019","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/jcb.22799","article-title":"Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer","volume":"111","author":"Bussard","year":"2010","journal-title":"J Cell Biochem"},{"key":"10.1002\/jcb.25895-BIB0020|jcb25895-cit-0020","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10549-010-1154-y","article-title":"Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome","volume":"128","author":"Campbell","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1002\/jcb.25895-BIB0021|jcb25895-cit-0021","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1002\/jcb.25895-BIB0022|jcb25895-cit-0022","first-page":"13","article-title":"Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-\u03b1-positive breast cancer","volume":"8","author":"Casneuf","year":"2016","journal-title":"Breast Cancer Targets Ther"},{"key":"10.1002\/jcb.25895-BIB0023|jcb25895-cit-0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4061\/2011\/572706","article-title":"Breast tumor angiogenesis and tumor-associated macrophages: Histopathologist's perspective","volume":"2011","author":"Ch'ng","year":"2011","journal-title":"Pathol Res Int"},{"key":"10.1002\/jcb.25895-BIB0024|jcb25895-cit-0024","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/cancers6031670","article-title":"Tumor-associated macrophages as major players in the tumor microenvironment","volume":"6","author":"Chanmee","year":"2014","journal-title":"Cancers"},{"key":"10.1002\/jcb.25895-BIB0025|jcb25895-cit-0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.imbio.2008.07.012","article-title":"Cisplatin primes murine peritoneal macrophages for enhanced expression of nitric oxide, proinflammatory cytokines, TLRs, transcription factors and activation of MAP kinases upon co-incubation with L929 cells","volume":"214","author":"Chauhan","year":"2009","journal-title":"Immunobiology"},{"key":"10.1002\/jcb.25895-BIB0026|jcb25895-cit-0026","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1021\/ml100010j","article-title":"Structure-based design of conformationally constrained, cell-permeable STAT3 inhibitors","volume":"1","author":"Chen","year":"2010","journal-title":"ACS Med Chem Lett"},{"key":"10.1002\/jcb.25895-BIB0027|jcb25895-cit-0027","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1074-7613(03)00232-2","article-title":"A critical role for Stat3 signaling in immune tolerance","volume":"19","author":"Cheng","year":"2003","journal-title":"Immunity"},{"key":"10.1002\/jcb.25895-BIB0028|jcb25895-cit-0028","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1158\/0008-5472.CAN-11-0103","article-title":"IL-12 release by engineered T cells expressing chimeric antigen receptors can effectively Muster an antigen-independent macrophage response on tumor cells that have shut down tumor antigen expression","volume":"71","author":"Chmielewski","year":"2011","journal-title":"Cancer Res"},{"key":"10.1002\/jcb.25895-BIB0029|jcb25895-cit-0029","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/74704","article-title":"Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets","volume":"6","author":"Clynes","year":"2000","journal-title":"Nat Med"},{"key":"10.1002\/jcb.25895-BIB0030|jcb25895-cit-0030","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"10.1002\/jcb.25895-BIB0031|jcb25895-cit-0031","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.coph.2013.05.017","article-title":"Tumour-associated macrophages and cancer","volume":"13","author":"Cook","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"10.1002\/jcb.25895-BIB0032|jcb25895-cit-0032","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep"},{"key":"10.1002\/jcb.25895-BIB0033|jcb25895-cit-0033","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0092-8674(03)00154-5","article-title":"HIF-1\u03b1 is essential for myeloid cell-mediated inflammation","volume":"112","author":"Cramer","year":"2003","journal-title":"Cell"},{"key":"10.1002\/jcb.25895-BIB0034|jcb25895-cit-0034","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/bjc.2014.149","article-title":"Trabectedin, a drug acting on both cancer cells and the tumour microenvironment","volume":"111","author":"D'incalci","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1002\/jcb.25895-BIB0035|jcb25895-cit-0035","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1158\/0008-5472.CAN-11-1261","article-title":"Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway","volume":"71","author":"Daurkin","year":"2011","journal-title":"Cancer Res"},{"key":"10.1002\/jcb.25895-BIB0036|jcb25895-cit-0036","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.7150\/ijbs.7.1239","article-title":"Macrophage migration inhibitory factor (MIF): A key player in protozoan infections","volume":"7","author":"de Dios Rosado","year":"2011","journal-title":"Int J Biol Sci"},{"key":"10.1002\/jcb.25895-BIB0037|jcb25895-cit-0037","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ccr.2013.02.013","article-title":"Macrophage regulation of tumor responses to anticancer therapies","volume":"23","author":"De Palma","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1002\/jcb.25895-BIB0038|jcb25895-cit-0038","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2159-8274.CD-10-0028","article-title":"Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy","volume":"1","author":"DeNardo","year":"2011","journal-title":"Cancer Discov"},{"key":"10.1002\/jcb.25895-BIB0039|jcb25895-cit-0039","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4048\/jbc.2014.17.1.25","article-title":"Dimethyl sulfoxide suppresses mouse 4T1 breast cancer growth by modulating tumor-associated macrophage differentiation","volume":"17","author":"Deng","year":"2014","journal-title":"J Breast Cancer"},{"key":"10.1002\/jcb.25895-BIB0040|jcb25895-cit-0040","first-page":"1032","volume-title":"Bisphosphonates: Mechanism of action and role in clinical practiceeditor^ editors. Mayo clinic proceedings","author":"Drake","year":"2008"},{"key":"10.1002\/jcb.25895-BIB0041|jcb25895-cit-0041","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.intimp.2010.07.002","article-title":"The multikinase inhibitor sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE 2 in murine macrophages","volume":"10","author":"Edwards","year":"2010","journal-title":"Int Immunopharmacol"},{"key":"10.1002\/jcb.25895-BIB0042|jcb25895-cit-0042","first-page":"2053646","article-title":"The response of macrophages and neutrophils to hypoxia in the context of cancer and other inflammatory diseases","volume":"2014","author":"Egners","year":"2016","journal-title":"Mediators Inflamm"},{"key":"10.1002\/jcb.25895-BIB0043|jcb25895-cit-0043","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1586\/era.12.147","article-title":"Breast cancer immunobiology driving immunotherapy: Vaccines and immune checkpoint blockade","volume":"12","author":"Emens","year":"2012","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1002\/jcb.25895-BIB0044|jcb25895-cit-0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jir.2014.0026","article-title":"The role of cytokines in breast cancer development and progression","volume":"35","author":"Esquivel-Vel\u00e1zquez","year":"2015","journal-title":"J Interferon Cytokine Res"},{"key":"10.1002\/jcb.25895-BIB0045|jcb25895-cit-0045","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1158\/0008-5472.CAN-08-1405","article-title":"Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages","volume":"69","author":"Eubank","year":"2009","journal-title":"Cancer Res"},{"key":"10.1002\/jcb.25895-BIB0046|jcb25895-cit-0046","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood-2010-01-261792","article-title":"Opposing roles for HIF-1\u03b1 and HIF-2\u03b1 in the regulation of angiogenesis by mononuclear phagocytes","volume":"117","author":"Eubank","year":"2011","journal-title":"Blood"},{"key":"10.1002\/jcb.25895-BIB0047|jcb25895-cit-0047","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1182\/blood-2008-12-195941","article-title":"Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia","volume":"114","author":"Fang","year":"2009","journal-title":"Blood"},{"key":"10.1002\/jcb.25895-BIB0048|jcb25895-cit-0048","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/cam4.186","article-title":"Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer","volume":"3","author":"Forghani","year":"2014","journal-title":"Cancer Med"},{"key":"10.1002\/jcb.25895-BIB0049|jcb25895-cit-0049","first-page":"251","article-title":"New perspectives: Role of Sunitinib in breast cancer","volume":"162","author":"Fratto","year":"2010","journal-title":"Clin Ter"},{"key":"10.1002\/jcb.25895-BIB0050|jcb25895-cit-0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbrc.2013.07.034","article-title":"CTLA-4Ig immunotherapy of obesity-induced insulin resistance by manipulation of macrophage polarization in adipose tissues","volume":"438","author":"Fujii","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/jcb.25895-BIB0051|jcb25895-cit-0051","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/ijc.24378","article-title":"Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression","volume":"125","author":"Fujimoto","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1002\/jcb.25895-BIB0052|jcb25895-cit-0052","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: A protein secreted by visceral fat that mimics the effects of insulin","volume":"307","author":"Fukuhara","year":"2005","journal-title":"Science"},{"key":"10.1002\/jcb.25895-BIB0053|jcb25895-cit-0053","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.mce.2013.03.023","article-title":"STAT signaling in different breast cancer sub-types","volume":"382","author":"Furth","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1002\/jcb.25895-BIB0054|jcb25895-cit-0054","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1002\/jcb.25895-BIB0055|jcb25895-cit-0055","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.imbio.2013.06.003","article-title":"Tumor associated macrophages and neutrophils in cancer","volume":"218","author":"Galdiero","year":"2013","journal-title":"Immunobiology"},{"key":"10.1002\/jcb.25895-BIB0056|jcb25895-cit-0056","volume-title":"Macrophage polarization in lung biology and diseaseseditor^ editors. Lung inflammation","author":"George","year":"2014"},{"key":"10.1002\/jcb.25895-BIB0057|jcb25895-cit-0057","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccr.2013.01.008","article-title":"Role of macrophage targeting in the antitumor activity of trabectedin","volume":"23","author":"Germano","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1002\/jcb.25895-BIB0058|jcb25895-cit-0058","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1749-6632.2012.06674.x","article-title":"The development of denosumab for the treatment of diseases of bone loss and cancer-induced bone destruction","volume":"1263","author":"Goessl","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1002\/jcb.25895-BIB0059|jcb25895-cit-0059","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/brv.12176","article-title":"MicroRNAs in breast cancer: Regulatory roles governing the hallmarks of cancer","volume":"91","author":"Goh","year":"2015","journal-title":"Biol Rev"},{"key":"10.1002\/jcb.25895-BIB0060|jcb25895-cit-0060","first-page":"1","article-title":"Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer","volume":"11","author":"Gonzalez","year":"2009","journal-title":"Breast Cancer Res"},{"key":"10.1002\/jcb.25895-BIB0061|jcb25895-cit-0061","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: Mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"key":"10.1002\/jcb.25895-BIB0062|jcb25895-cit-0062","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-824X-5-20","article-title":"The role of tumor-associated macrophages in tumor vascularization","volume":"5","author":"Guo","year":"2013","journal-title":"Vasc Cell"},{"key":"10.1002\/jcb.25895-BIB0063|jcb25895-cit-0063","doi-asserted-by":"crossref","first-page":"948098","DOI":"10.1155\/2012\/948098","article-title":"Macrophages in tumor microenvironments and the progression of tumors","volume":"2012","author":"Hao","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1002\/jcb.25895-BIB0064|jcb25895-cit-0064","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/imr.12216","article-title":"A decade of progress in adipose tissue macrophage biology","volume":"262","author":"Hill","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1002\/jcb.25895-BIB0065|jcb25895-cit-0065","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1158\/1078-0432.CCR-12-2603","article-title":"Molecular pathways: Adipose inflammation as a mediator of obesity-associated cancer","volume":"19","author":"Howe","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1002\/jcb.25895-BIB0066|jcb25895-cit-0066","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1158\/1078-0432.CCR-06-2313","article-title":"Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: Clinical implications","volume":"13","author":"Huang","year":"2007","journal-title":"Clin. Cancer Res"},{"key":"10.1002\/jcb.25895-BIB0067|jcb25895-cit-0067","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/1471-2407-13-421","article-title":"Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization","volume":"13","author":"Jang","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1002\/jcb.25895-BIB0068|jcb25895-cit-0068","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10549-014-3164-7","article-title":"Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs","volume":"148","author":"Jia","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1002\/jcb.25895-BIB0069|jcb25895-cit-0069","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1631\/jzus.B1300264","article-title":"Harnessing the immune system for the treatment of breast cancer","volume":"15","author":"Jiang","year":"2014","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1002\/jcb.25895-BIB0070|jcb25895-cit-0070","doi-asserted-by":"crossref","first-page":"e10993","DOI":"10.1371\/journal.pone.0010993","article-title":"An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis","volume":"5","author":"Jin","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1002\/jcb.25895-BIB0071|jcb25895-cit-0071","first-page":"123","article-title":"Tumor-associated macrophages as an emerging target against tumors: Creating a new path from bench to bedside","volume":"1855","author":"Jinushi","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/jcb.25895-BIB0072|jcb25895-cit-0072","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/jcb.21230","article-title":"Immune cells as anti-cancer therapeutic targets and tools","volume":"101","author":"Johansson","year":"2007","journal-title":"J Cell Biochem"},{"key":"10.1002\/jcb.25895-BIB0073|jcb25895-cit-0073","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: Regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"10.1002\/jcb.25895-BIB0074|jcb25895-cit-0074","doi-asserted-by":"crossref","first-page":"11389","DOI":"10.1038\/srep11389","article-title":"Morphine modulates interleukin-4-or breast cancer cell-induced pro-metastatic activation of macrophages","volume":"5","author":"Khabbazi","year":"2015","journal-title":"Sci Rep"},{"key":"10.1002\/jcb.25895-BIB0075|jcb25895-cit-0075","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.cytogfr.2013.10.001","article-title":"Role of adipokines and cytokines in obesity-associated breast cancer: Therapeutic targets","volume":"24","author":"Khan","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1002\/jcb.25895-BIB0076|jcb25895-cit-0076","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.phrs.2015.08.004","article-title":"Therapeutic potential of chemokine signal inhibition for metastatic breast cancer","volume":"100","author":"Kitamura","year":"2015","journal-title":"Pharmacol Res"},{"key":"10.1002\/jcb.25895-BIB0077|jcb25895-cit-0077","doi-asserted-by":"crossref","first-page":"13007","DOI":"10.1038\/ncomms13007","article-title":"Obesity-associated NLRC4 inflammasome activation drives breast cancer progression","volume":"7","author":"Kolb","year":"2016","journal-title":"Nat Commun"},{"key":"10.1002\/jcb.25895-BIB0078|jcb25895-cit-0078","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.20082173","article-title":"Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD- L1","volume":"206","author":"Kuang","year":"2009","journal-title":"J Exp Med"},{"key":"10.1002\/jcb.25895-BIB0079|jcb25895-cit-0079","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2302\/kjm.61.47","article-title":"Tumor angiogenesis and anti-angiogenic therapy","volume":"61","author":"Kubota","year":"2012","journal-title":"Keio J Med"},{"key":"10.1002\/jcb.25895-BIB0080|jcb25895-cit-0080","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1084\/jem.20081605","article-title":"M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis","volume":"206","author":"Kubota","year":"2009","journal-title":"J Exp Med"},{"key":"10.1002\/jcb.25895-BIB0081|jcb25895-cit-0081","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/nature03491","article-title":"IKK\u03b1 limits macrophage NF-\u03baB activation and contributes to the resolution of inflammation","volume":"434","author":"Lawrence","year":"2005","journal-title":"Nature"},{"key":"10.1002\/jcb.25895-BIB0082|jcb25895-cit-0082","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nri3088","article-title":"Transcriptional regulation of macrophage polarization: Enabling diversity with identity","volume":"11","author":"Lawrence","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1002\/jcb.25895-BIB0083|jcb25895-cit-0083","doi-asserted-by":"crossref","first-page":"10016","DOI":"10.18632\/oncotarget.3540","article-title":"Stat3 orchestrates interaction between endothelial and tumor cells and inhibition of Stat3 suppresses brain metastasis of breast cancer cells","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"10.1002\/jcb.25895-BIB0084|jcb25895-cit-0084","first-page":"170","article-title":"Recruitment of monocytes\/macrophages in different tumor microenvironments","volume":"1835","author":"Lee","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/jcb.25895-BIB0085|jcb25895-cit-0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1020304003704","article-title":"Tumor-associated macrophages in breast cancer","volume":"7","author":"Leek","year":"2002","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1002\/jcb.25895-BIB0086|jcb25895-cit-0086","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00262-007-0389-x","article-title":"A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis","volume":"57","author":"Lew\u0113n","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"10.1002\/jcb.25895-BIB0087|jcb25895-cit-0087","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0002-9440(10)62038-X","article-title":"Macrophage responses to hypoxia","volume":"167","author":"Lewis","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1002\/jcb.25895-BIB0088|jcb25895-cit-0088","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/jcb.21159","article-title":"Tumor microenvironment: The role of the tumor stroma in cancer","volume":"101","author":"Li","year":"2007","journal-title":"J Cell Biochem"},{"key":"10.1002\/jcb.25895-BIB0089|jcb25895-cit-0089","doi-asserted-by":"crossref","first-page":"520","DOI":"10.5306\/wjco.v5.i3.520","article-title":"Green tea compounds in breast cancer prevention and treatment","volume":"5","author":"Li","year":"2014","journal-title":"World J Clin Oncol"},{"key":"10.1002\/jcb.25895-BIB0090|jcb25895-cit-0090","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bbrc.2004.07.039","article-title":"STAT3 activation in macrophages following infection with Salmonella","volume":"321","author":"Lin","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/jcb.25895-BIB0091|jcb25895-cit-0091","first-page":"2957","article-title":"Overexpression of legumain in tumors is significant for invasion\/metastasis and a candidate enzymatic target for prodrug therapy","volume":"63","author":"Liu","year":"2003","journal-title":"Cancer Res"},{"key":"10.1002\/jcb.25895-BIB0092|jcb25895-cit-0092","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.4161\/cbt.21781","article-title":"A novel 7-bromoindirubin with potent anticancer activity suppresses survival of human melanoma cells associated with inhibition of STAT3 and Akt signaling","volume":"13","author":"Liu","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"10.1002\/jcb.25895-BIB0093|jcb25895-cit-0093","doi-asserted-by":"crossref","first-page":"520","DOI":"10.7150\/ijbs.8879","article-title":"Macrophage polarization in inflammatory diseases","volume":"10","author":"Liu","year":"2014","journal-title":"Int J Biol Sci"},{"key":"10.1002\/jcb.25895-BIB0094|jcb25895-cit-0094","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10549-011-1432-3","article-title":"The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: Results from the Nurses' Health Study","volume":"129","author":"Liu","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1002\/jcb.25895-BIB0095|jcb25895-cit-0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1677\/erc.1.00729","article-title":"Molecular links between obesity and breast cancer","volume":"13","author":"Lorincz","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1002\/jcb.25895-BIB0096|jcb25895-cit-0096","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nature05656","article-title":"Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin","volume":"446","author":"Luo","year":"2007","journal-title":"Nature"},{"key":"10.1002\/jcb.25895-BIB0097|jcb25895-cit-0097","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1172\/JCI27648","article-title":"Targeting tumor-associated macrophages as a novel strategy against breast cancer","volume":"116","author":"Luo","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1002\/jcb.25895-BIB0098|jcb25895-cit-0098","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/cmi.2012.69","article-title":"CCL5 as a potential immunotherapeutic target in triple-negative breast cancer","volume":"10","author":"Lv","year":"2013","journal-title":"Cell Mol Immunol"},{"key":"10.1002\/jcb.25895-BIB0099|jcb25895-cit-0099","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1100\/2011\/806787","article-title":"Obesity, inflammation, and postmenopausal breast cancer: Therapeutic implications","volume":"11","author":"Macci\u00f2","year":"2011","journal-title":"Sci World J"},{"key":"10.1002\/jcb.25895-BIB0100|jcb25895-cit-0100","doi-asserted-by":"crossref","first-page":"8970","DOI":"10.1021\/acs.jmedchem.5b01321","article-title":"Targeting the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 6 (STAT6) with Cell-Permeable, Phosphatase-Stable Phosphopeptide Mimics Potently Inhibits Tyr641 Phosphorylation and Transcriptional Activity","volume":"58","author":"Mandal","year":"2015","journal-title":"J Med Chem"},{"key":"10.1002\/jcb.25895-BIB0101|jcb25895-cit-0101","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1158\/1535-7163.MCT-09-0255","article-title":"JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor\/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia","volume":"8","author":"Manthey","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/jcb.25895-BIB0102|jcb25895-cit-0102","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1002\/eji.201141894","article-title":"Cancer-promoting tumor-associated macrophages: New vistas and open questions","volume":"41","author":"Mantovani","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1002\/jcb.25895-BIB0103|jcb25895-cit-0103","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1002\/jcb.25895-BIB0104|jcb25895-cit-0104","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1172\/JCI44745","article-title":"The JAK2\/STAT3 signaling pathway is required for growth of CD44+ CD24-stem cell-like breast cancer cells in human tumors","volume":"121","author":"Marotta","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1002\/jcb.25895-BIB0105|jcb25895-cit-0105","doi-asserted-by":"crossref","first-page":"12703","DOI":"10.12703\/P6-13","article-title":"The M1 and M2 paradigm of macrophage activation: Time for reassessment","volume":"6","author":"Martinez","year":"2014","journal-title":"F1000Prime Rep"},{"key":"10.1002\/jcb.25895-BIB0106|jcb25895-cit-0106","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.181.5.3099","article-title":"Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells","volume":"181","author":"Matsumura","year":"2008","journal-title":"J Immunol"},{"key":"10.1002\/jcb.25895-BIB0107|jcb25895-cit-0107","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.4049\/jimmunol.174.6.3281","article-title":"\u0394-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response","volume":"174","author":"McKallip","year":"2005","journal-title":"J Immunol"},{"key":"10.1002\/jcb.25895-BIB0108|jcb25895-cit-0108","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1200\/JCO.2005.05.098","article-title":"Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer","volume":"23","author":"Miller","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1002\/jcb.25895-BIB0109|jcb25895-cit-0109","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.intimp.2012.11.016","article-title":"Optimized dosing of a CCR2 antagonist for amplification of vaccine immunity","volume":"15","author":"Mitchell","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"10.1002\/jcb.25895-BIB0110|jcb25895-cit-0110","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1158\/0008-5472.CAN-12-2731","article-title":"Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses","volume":"73","author":"Mitchem","year":"2013","journal-title":"Cancer Res"},{"key":"10.1002\/jcb.25895-BIB0111|jcb25895-cit-0111","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ccr.2005.06.016","article-title":"Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity","volume":"8","author":"Moeller","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1002\/jcb.25895-BIB0112|jcb25895-cit-0112","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2217\/fon.10.41","article-title":"Clinical overview of sorafenib in breast cancer","volume":"6","author":"Moreno-Aspitia","year":"2010","journal-title":"Future Oncol"},{"key":"10.1002\/jcb.25895-BIB0113|jcb25895-cit-0113","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1002\/jcb.25895-BIB0114|jcb25895-cit-0114","first-page":"91","article-title":"Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics","volume":"1","author":"Mukhtar","year":"2014","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1002\/jcb.25895-BIB0115|jcb25895-cit-0115","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1002\/1521-4141(2002010)32:10<2866::AID-IMMU2866>3.0.CO;2-V","article-title":"IFN-\u03b3 and pro-inflammatory cytokine production by antigen-presenting cells is dictated by intracellular thiol redox status regulated by oxygen tension","volume":"32","author":"Murata","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1002\/jcb.25895-BIB0116|jcb25895-cit-0116","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ccr.2012.02.017","article-title":"Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance","volume":"21","author":"Nakasone","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1002\/jcb.25895-BIB0117|jcb25895-cit-0117","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1073\/pnas.0409467102","article-title":"Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells","volume":"102","author":"Nam","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1002\/jcb.25895-BIB0118|jcb25895-cit-0118","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1158\/0008-5472.CAN-11-0669","article-title":"S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways","volume":"72","author":"Nasser","year":"2012","journal-title":"Cancer Res"},{"key":"10.1002\/jcb.25895-BIB0119|jcb25895-cit-0119","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2014.11.004","article-title":"Targeting breast cancer through its microenvironment: Current status of preclinical and clinical research in finding relevant targets","volume":"147","author":"Nienhuis","year":"2015","journal-title":"Pharmacol Ther"},{"key":"10.1002\/jcb.25895-BIB0120|jcb25895-cit-0120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.surg.2008.08.038","article-title":"Inflammation in obesity-related disease","volume":"145","author":"O'Rourke","year":"2009","journal-title":"Surgery"},{"key":"10.1002\/jcb.25895-BIB0121|jcb25895-cit-0121","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3892\/ijo.2013.1938","article-title":"The role of tumor-associated macrophages in breast cancer progression (review)","volume":"43","author":"Obeid","year":"2013","journal-title":"Int J Oncol"},{"key":"10.1002\/jcb.25895-BIB0122|jcb25895-cit-0122","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1111\/j.1582-4934.2009.00876.x","article-title":"Development of HIF-1 inhibitors for cancer therapy","volume":"13","author":"Onnis","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1002\/jcb.25895-BIB0123|jcb25895-cit-0123","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000028084","article-title":"Activation or destruction of T cells via macrophages","volume":"67","author":"Orlikowsky","year":"2000","journal-title":"Pathobiology"},{"key":"10.1002\/jcb.25895-BIB0124|jcb25895-cit-0124","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.it.2015.02.004","article-title":"Macrophages and cancer: From mechanisms to therapeutic implications","volume":"36","author":"Ostuni","year":"2015","journal-title":"Trends Immunol"},{"key":"10.1002\/jcb.25895-BIB0125|jcb25895-cit-0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6750-11-90","article-title":"Design and development of a peptide-based adiponectin receptor agonist for cancer treatment","volume":"11","author":"Otvos","year":"2011","journal-title":"BMC Biotechnol"},{"key":"10.1002\/jcb.25895-BIB0126|jcb25895-cit-0126","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1517\/13543776.2011.539205","article-title":"Signal transducer and activator of transcription 3 inhibitors: A patent review","volume":"21","author":"Page","year":"2011","journal-title":"Expert Opin Ther Pat"},{"key":"10.1002\/jcb.25895-BIB0127|jcb25895-cit-0127","doi-asserted-by":"crossref","first-page":"849720","DOI":"10.1155\/2014\/849720","article-title":"The role of chemokines in breast cancer pathology and its possible use as therapeutic targets","volume":"2014","author":"Palacios-Arreola","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1002\/jcb.25895-BIB0128|jcb25895-cit-0128","doi-asserted-by":"crossref","DOI":"10.2217\/imt.13.102","article-title":"argeting tumor-infiltrating macrophages to combat cancer","author":"Panni","year":"2013","journal-title":"Immunotherapy"},{"key":"10.1002\/jcb.25895-BIB0129|jcb25895-cit-0129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1755-1536-5-S1-S9","article-title":"Role of matrix metaloproteases in idiopathic pulmonary fibrosis","volume":"5","author":"Pardo","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1002\/jcb.25895-BIB0130|jcb25895-cit-0130","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cell.2007.08.009","article-title":"Innate immune response triggers lupus-like autoimmune disease","volume":"130","author":"Paulson","year":"2007","journal-title":"Cell"},{"key":"10.1002\/jcb.25895-BIB0131|jcb25895-cit-0131","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1158\/0008-5472.CAN-05-3523","article-title":"Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts","volume":"66","author":"Paulus","year":"2006","journal-title":"Cancer Res"},{"key":"10.1002\/jcb.25895-BIB0132|jcb25895-cit-0132","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1182\/blood-2011-02-339911","article-title":"Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology","volume":"119","author":"Pello","year":"2012","journal-title":"Blood"},{"key":"10.1002\/jcb.25895-BIB0133|jcb25895-cit-0133","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.imbio.2009.06.014","article-title":"Cellular and molecular pathways linking inflammation and cancer","volume":"214","author":"Porta","year":"2009","journal-title":"Immunobiology"},{"key":"10.1002\/jcb.25895-BIB0134|jcb25895-cit-0134","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1182\/blood-2009-08-237412","article-title":"Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: Combating tumor evasion of antiangiogenic therapy","volume":"115","author":"Priceman","year":"2010","journal-title":"Blood"},{"key":"10.1002\/jcb.25895-BIB0135|jcb25895-cit-0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1002\/jcb.25895-BIB0136|jcb25895-cit-0136","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1749-6632.2009.04939.x","article-title":"Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells","volume":"1174","author":"Rech","year":"2009","journal-title":"Ann NY Acad Sci"},{"key":"10.1002\/jcb.25895-BIB0137|jcb25895-cit-0137","first-page":"8360","article-title":"A chemokine receptor antagonist inhibits experimental breast tumor growth","volume":"63","author":"Robinson","year":"2003","journal-title":"Cancer Res"},{"key":"10.1002\/jcb.25895-BIB0138|jcb25895-cit-0138","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cellimm.2013.06.008","article-title":"Tumor microenvironment profoundly modifies functional status of macrophages: Peritoneal and tumor-associated macrophages are two very different subpopulations","volume":"283","author":"Rodr\u00edguez","year":"2013","journal-title":"Cell Immunol"},{"key":"10.1002\/jcb.25895-BIB0139|jcb25895-cit-0139","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1158\/0008-5472.CAN-04-0465","article-title":"Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses","volume":"64","author":"Rodriguez","year":"2004","journal-title":"Cancer Res"},{"key":"10.1002\/jcb.25895-BIB0140|jcb25895-cit-0140","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ccell.2014.09.006","article-title":"Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells","volume":"26","author":"Ruffell","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1002\/jcb.25895-BIB0141|jcb25895-cit-0141","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","article-title":"Macrophages and therapeutic resistance in cancer","volume":"27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1002\/jcb.25895-BIB0142|jcb25895-cit-0142","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1667\/0033-7587(2001)155[0151:TPONTO]2.0.CO;2","article-title":"The pathway of neoplastic transformation of human breast epithelial cells","volume":"155","author":"Russo","year":"2001","journal-title":"Radiat Res"},{"key":"10.1002\/jcb.25895-BIB0143|jcb25895-cit-0143","doi-asserted-by":"crossref","first-page":"11432","DOI":"10.1158\/0008-5472.CAN-06-1867","article-title":"P50 nuclear factor-\u03baB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance","volume":"66","author":"Saccani","year":"2006","journal-title":"Cancer Res"},{"key":"10.1002\/jcb.25895-BIB0144|jcb25895-cit-0144","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00280-013-2099-8","article-title":"A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors","volume":"71","author":"Sandhu","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1002\/jcb.25895-BIB0145|jcb25895-cit-0145","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.18632\/oncotarget.1426","article-title":"Chemokines in tumor progression and metastasis","volume":"4","author":"Sarvaiya","year":"2013","journal-title":"Oncotarget"},{"key":"10.1002\/jcb.25895-BIB0146|jcb25895-cit-0146","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1084\/jem.20030267","article-title":"Regulation of the chemokine receptor CXCR4 by hypoxia","volume":"198","author":"Schioppa","year":"2003","journal-title":"J Exp Med"},{"key":"10.1002\/jcb.25895-BIB0147|jcb25895-cit-0147","first-page":"289","volume-title":"Differentiation and gene expression profile of tumor-associated macrophageseditor^ editors. Seminars in cancer biology","author":"Schmieder","year":"2012"},{"key":"10.1002\/jcb.25895-BIB0148|jcb25895-cit-0148","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fimmu.2015.00236","article-title":"Hyaluronan, inflammation and Breast cancer progression","volume":"6","author":"Schwertfeger","year":"2015","journal-title":"Front Immunol"},{"key":"10.1002\/jcb.25895-BIB0149|jcb25895-cit-0149","doi-asserted-by":"crossref","first-page":"580971","DOI":"10.1155\/2010\/580971","article-title":"Hypoxia-inducible factor-1 as a therapeutic target in endometrial cancer management","volume":"2010","author":"Seeber","year":"2010","journal-title":"Obstet Gynecol Int"},{"key":"10.1002\/jcb.25895-BIB0150|jcb25895-cit-0150","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1002\/jcb.25895-BIB0151|jcb25895-cit-0151","doi-asserted-by":"crossref","unstructured":"Sharma N Wesolowski R Reebel L Rodal MB Peck A West B Karlin DA Dowlati A Le MH Coussens LM 2014 TPS3127","DOI":"10.1200\/jco.2014.32.15_suppl.tps3127"},{"key":"10.1002\/jcb.25895-BIB0152|jcb25895-cit-0152","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2217\/fon.11.145","article-title":"Curcumin molecular targets in obesity and obesity-related cancers","volume":"8","author":"Shehzad","year":"2012","journal-title":"Future Oncol"},{"key":"10.1002\/jcb.25895-BIB0153|jcb25895-cit-0153","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1101\/gad.180331.111","article-title":"Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer","volume":"25","author":"Shree","year":"2011","journal-title":"Genes Dev"},{"key":"10.1002\/jcb.25895-BIB0154|jcb25895-cit-0154","first-page":"349","volume-title":"Macrophage polarization in tumour progressioneditor^ editors. Seminars in cancer biology","author":"Sica","year":"2008"},{"key":"10.1002\/jcb.25895-BIB0155|jcb25895-cit-0155","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: In vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1002\/jcb.25895-BIB0156|jcb25895-cit-0156","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4049\/jimmunol.164.2.762","article-title":"Autocrine production of IL-10 mediates defective IL-12 production and NF-\u03baB activation in tumor-associated macrophages","volume":"164","author":"Sica","year":"2000","journal-title":"J Immunol"},{"key":"10.1002\/jcb.25895-BIB0157|jcb25895-cit-0157","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.4049\/jimmunol.1302821","article-title":"CCL2 shapes macrophage polarization by GM-CSF and M-CSF: Identification of CCL2\/CCR2-dependent gene expression profile","volume":"192","author":"Sierra-Filardi","year":"2014","journal-title":"J Immunol"},{"key":"10.1002\/jcb.25895-BIB0158|jcb25895-cit-0158","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2230.2004.01593.x","article-title":"Topical imidazoquinoline therapy of cutaneous squamous cell carcinoma polarizes lymphoid and monocyte\/macrophage populations to a Th1 and M1 cytokine pattern","volume":"29","author":"Smith","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1002\/jcb.25895-BIB0159|jcb25895-cit-0159","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1002\/jcb.25895-BIB0160|jcb25895-cit-0160","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1189\/jlb.0609385","article-title":"Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation","volume":"86","author":"Solinas","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1002\/jcb.25895-BIB0161|jcb25895-cit-0161","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.canlet.2008.03.018","article-title":"The inflammatory chemokines CCL2 and CCL5 in breast cancer","volume":"267","author":"Soria","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1002\/jcb.25895-BIB0162|jcb25895-cit-0162","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mam.2011.04.005","article-title":"Macrophage regulation of tumor angiogenesis: Implications for cancer therapy","volume":"32","author":"Squadrito","year":"2011","journal-title":"Mol Aspects Med"},{"key":"10.1002\/jcb.25895-BIB0163|jcb25895-cit-0163","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1758834012475152","article-title":"Immunotherapeutic approaches in triple-negative breast cancer: Latest research and clinical prospects","volume":"5","author":"Stagg","year":"2013","journal-title":"Ther Adv Med Oncol"},{"key":"10.1002\/jcb.25895-BIB0164|jcb25895-cit-0164","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s10549-011-1789-3","article-title":"Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression","volume":"131","author":"Sun","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1002\/jcb.25895-BIB0165|jcb25895-cit-0165","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1158\/0008-5472.CAN-12-0122","article-title":"Tumor microenvironment complexity: Emerging roles in cancer therapy","volume":"72","author":"Swartz","year":"2012","journal-title":"Cancer Res"},{"key":"10.1002\/jcb.25895-BIB0166|jcb25895-cit-0166","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cmet.2009.08.003","article-title":"Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance","volume":"10","author":"Tabata","year":"2009","journal-title":"Cell Metab"},{"key":"10.1002\/jcb.25895-BIB0167|jcb25895-cit-0167","unstructured":"Tamkus D Joginpally T. 2016"},{"key":"10.1002\/jcb.25895-BIB0168|jcb25895-cit-0168","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.canlet.2013.01.024","article-title":"Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer","volume":"332","author":"Tang","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1002\/jcb.25895-BIB0169|jcb25895-cit-0169","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/imm.12023","article-title":"Anti-tumour strategies aiming to target tumour-associated macrophages","volume":"138","author":"Tang","year":"2013","journal-title":"Immunology"},{"key":"10.1002\/jcb.25895-BIB0170|jcb25895-cit-0170","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1002\/jcb.25230","article-title":"Essential role of lysophosphatidylcholine acyltransferase 3 in the induction of macrophage polarization in PMA-treated U937 cells","volume":"116","author":"Taniguchi","year":"2015","journal-title":"J Cell Biochem"},{"key":"10.1002\/jcb.25895-BIB0171|jcb25895-cit-0171","first-page":"421","article-title":"Leptin expression in colorectal and breast cancer patients","volume":"5","author":"Tessitore","year":"2000","journal-title":"Int J Mol Med"},{"key":"10.1002\/jcb.25895-BIB0172|jcb25895-cit-0172","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/his.12607","article-title":"High numbers of macrophages, especially M2-like (CD163-positive), correlate with hyaluronan accumulation and poor outcome in breast cancer","volume":"66","author":"Tiainen","year":"2015","journal-title":"Histopathology"},{"key":"10.1002\/jcb.25895-BIB0173|jcb25895-cit-0173","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1158\/0008-5472.CAN-11-3567","article-title":"CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells","volume":"72","author":"Tsuyada","year":"2012","journal-title":"Cancer Res"},{"key":"10.1002\/jcb.25895-BIB0174|jcb25895-cit-0174","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/jid.2008.310","article-title":"Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction","volume":"129","author":"Tjiu","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1002\/jcb.25895-BIB0175|jcb25895-cit-0175","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4049\/jimmunol.181.1.808","article-title":"Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3\/CD28 promotes the expansion of activated tumor reactive cells","volume":"181","author":"Vasir","year":"2008","journal-title":"J Immunol"},{"key":"10.1002\/jcb.25895-BIB0176|jcb25895-cit-0176","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1309\/0864AF2U3LGPCF3J","article-title":"Elevated serum levels of vascular endothelial growth factor are associated with tumor-associated macrophages in primary breast cancer","volume":"125","author":"Vicioso","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1002\/jcb.25895-BIB0177|jcb25895-cit-0177","first-page":"347","article-title":"The relationship between obesity and cancer","volume":"116","author":"VU\u010cENIK","year":"2014","journal-title":"Period Biol"},{"key":"10.1002\/jcb.25895-BIB0178|jcb25895-cit-0178","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.4049\/jimmunol.178.3.1357","article-title":"IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo","volume":"178","author":"Watkins","year":"2007","journal-title":"J Immunol"},{"key":"10.1002\/jcb.25895-BIB0179|jcb25895-cit-0179","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10549-014-3037-0","article-title":"Exosomal miR-221\/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells","volume":"147","author":"Wei","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1002\/jcb.25895-BIB0180|jcb25895-cit-0180","first-page":"311","volume-title":"Unraveling the microenvironmental influences on the normal mammary gl and and breast cancereditor^ editors. Seminars in cancer biology","author":"Weigelt","year":"2008"},{"key":"10.1002\/jcb.25895-BIB0181|jcb25895-cit-0181","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nri2744","article-title":"Monoclonal antibodies: Versatile platforms for cancer immunotherapy","volume":"10","author":"Weiner","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1002\/jcb.25895-BIB0182|jcb25895-cit-0182","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1158\/1535-7163.233.3.3","article-title":"Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1\u03b1","volume":"3","author":"Welsh","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/jcb.25895-BIB0183|jcb25895-cit-0183","doi-asserted-by":"crossref","first-page":"15025","DOI":"10.1038\/npjbcancer.2015.25","article-title":"Tumor-associated macrophages: Unwitting accomplices in breast cancer malignancy","volume":"2","author":"Williams","year":"2016","journal-title":"NPJ Beast Cancer"},{"key":"10.1002\/jcb.25895-BIB0184|jcb25895-cit-0184","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1158\/1078-0432.CCR-06-0074","article-title":"The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients","volume":"12","author":"Yaal-Hahoshen","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1002\/jcb.25895-BIB0185|jcb25895-cit-0185","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/sj.bjc.6603142","article-title":"A phase II study of Yondelis\u00ae(trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer","volume":"94","author":"Zelek","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1002\/jcb.25895-BIB0186|jcb25895-cit-0186","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/jcb.24139","article-title":"Furanodiene enhances tamoxifen-induced growth inhibitory activity of ERa-positive breast cancer cells in a PPAR\u03b3 independent manner","volume":"113","author":"Zhong","year":"2012","journal-title":"J Cell Biochem"},{"key":"10.1002\/jcb.25895-BIB0187|jcb25895-cit-0187","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1038\/ncomms5696","article-title":"TSC1 controls macrophage polarization to prevent inflammatory disease","volume":"5","author":"Zhu","year":"2014a","journal-title":"Nat Commun"},{"key":"10.1002\/jcb.25895-BIB0188|jcb25895-cit-0188","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1200\/JCO.2007.15.6521","article-title":"High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma","volume":"26","author":"Zhu","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1002\/jcb.25895-BIB0189|jcb25895-cit-0189","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1158\/0008-5472.CAN-13-3723","article-title":"CSF1\/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models","volume":"74","author":"Zhu","year":"2014b","journal-title":"Cancer Res"},{"key":"10.1002\/jcb.25895-BIB0190|jcb25895-cit-0190","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1158\/2326-6066.CIR-14-0226","article-title":"Induced PD-L1 expression mediates acquired resistance to agonistic anti-CD40 treatment","volume":"3","author":"Zippelius","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1002\/jcb.25895-BIB0191|jcb25895-cit-0191","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10585-012-9473-5","article-title":"Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models","volume":"29","author":"Zollo","year":"2012","journal-title":"Clin Exp Metastasis"}],"container-title":["Journal of Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcb.25895","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jcb.25895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T09:53:48Z","timestamp":1658483628000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcb.25895"}},"subtitle":["A<scp>NTI<\/scp>-C<scp>ANCER<\/scp>S<scp>TRATEGIES<\/scp><scp>TO<\/scp>T<scp>ARGET<\/scp>TAMs<scp>IN<\/scp>B<scp>REAST<\/scp>C<scp>ANCER<\/scp>"],"short-title":[],"issued":{"date-parts":[[2017,5,30]]},"references-count":191,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"URL":"https:\/\/doi.org\/10.1002\/jcb.25895","archive":["Portico"],"relation":{},"ISSN":["0730-2312"],"issn-type":[{"value":"0730-2312","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5,30]]}}}